Showing results (1701-1710 of 11,027) with videos related to
Sort By:
Pageof 1,103
Journal of the National Cancer Institute|June 1, 1975
Isolation and characterization of viruses from natural outbreaks of reticuloendotheliosis in turkeysP S Sarma, D K Jain, N K Mishra, et al.Journal of the National Cancer Institute|June 1, 1975
R-type virus-like particles in avian sarcoma virus-induced rat central nervous system tumorsM W Cloyd, P C Burger, D D BignerJournal of the National Cancer Institute|November 6, 1991
Hyaluronidase levels in urine from Wilms' tumor patientsM Stern, M T Longaker, N S Adzick, et al.Journal of the National Cancer Institute|December 18, 1991
Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, CaliforniaM C Yu, M J Tong, S Govindarajan, et al.Journal of the National Cancer Institute|October 16, 1991
Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancerI L Avis, T O Kovacs, P G Kasprzyk, et al.Journal of the National Cancer Institute|March 16, 2006
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skinMargaret R Karagas, Heather H Nelson, Peter Sehr, et al.Journal of the National Cancer Institute|March 16, 2006
Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and menSusanna C Larsson, Niclas Håkansson, Edward Giovannucci, et al.Journal of the National Cancer Institute|March 16, 2006
Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeoliteY Izzettin Baris, Philippe GrandjeanJournal of the National Cancer Institute|March 5, 2004
Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trialPatricia A Ganz, Lorna Kwan, Annette L Stanton, et al.Journal of the National Cancer Institute|April 8, 2004
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failureAnthony V D'Amico, Judd W Moul, Peter R Carroll, et al.Pageof 1,103